Lobbying Income
$220K
Filings
21
Unique Clients
4
Active Period
2007–2011
Registrant-reported income from clients on LDA filings
Largest clients by registrant-reported income
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Home Health Care Planning Improvement Act of 2007
2007 · year_end · Client: ADVANCED CLINICAL CONSULTANTS LLC
Health Information Technology for Low-Income Communities S. 1678, Home Health Care Planning Improvement Act
Client expense: — · Firm income: —
Matched citations: S. 1678
Food and Drug Administration Amendments Act of 2007
2007 · year_end · Client: FOREST LABORATORIES INC
H.R. 2900 Prescription Drug User Fee Authorization Act (treatment of certain enantiomer drugs; S. 1082 FDA Revitalization Act, Sec. 264 (treatment of certain enantiomer drugs; re-importation.
Client expense: — · Firm income: $160,000
Matched citations: H.R. 2900
Medicare Prescription Drug Savings for Our Seniors (Medicare Prescription Drug SOS) Act of 2007
2007 · year_end · Client: FOREST LABORATORIES INC
H.R. 3025, Medicre Prescription Drug Savings for Our Seniors Act of 2007, Sec. 505, COverage of mental health drugs under Medicare Part D; H.R. 3162, Children's Health and Medicare Protections Act of 2007, Sec. 225, Coverage of mental health drugs under Medicare part D; S.3 Access to Critical Medications under Medicate Part D.
Client expense: — · Firm income: $160,000
Matched citations: H.R. 3025
Medicare Prescription Drug Price Negotiation Act of 2007
2007 · year_end · Client: FOREST LABORATORIES INC
H.R. 3025, Medicre Prescription Drug Savings for Our Seniors Act of 2007, Sec. 505, COverage of mental health drugs under Medicare Part D; H.R. 3162, Children's Health and Medicare Protections Act of 2007, Sec. 225, Coverage of mental health drugs under Medicare part D; S.3 Access to Critical Medications under Medicate Part D.
Client expense: — · Firm income: $160,000
Matched citations: S.3
Food and Drug Administration Amendments Act of 2007
2007 · mid_year · Client: FOREST LABORATORIES INC
H.R. 2900, Prescription Drug User Fee Reauthorization Act, (treatment of certain enantiomer drugs; S. 1082, FDA Revitalization Act, Sec. 264, (treatment of certain enantiomer drugs).
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2900
Medicare Prescription Drug Savings for Our Seniors (Medicare Prescription Drug SOS) Act of 2007
2007 · mid_year · Client: FOREST LABORATORIES INC
H.R. 3025, Medicare Prescription Drug Savings for Our Seniors Act of 2007, Sec. 505, Coverage of mental health drugs under Medicare part D;, H.R. 3162, Children's Health and Medicare Protection Act of 2007, Sec. 225, Coverage of mental health drugs under Medicare Part D; S.3 Access to Critical Medications under Medicare Part D.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 3025
Medicare Prescription Drug Price Negotiation Act of 2007
2007 · mid_year · Client: FOREST LABORATORIES INC
H.R. 3025, Medicare Prescription Drug Savings for Our Seniors Act of 2007, Sec. 505, Coverage of mental health drugs under Medicare part D;, H.R. 3162, Children's Health and Medicare Protection Act of 2007, Sec. 225, Coverage of mental health drugs under Medicare Part D; S.3 Access to Critical Medications under Medicare Part D.
Client expense: — · Firm income: $20,000
Matched citations: S.3
Source: Senate LDA